Roche acquires long-term biotech partner

Thursday, 09. September 2021 09:40

Roche Holding AG announced on Thursday it has acquired its long-term partner, the biotechnological company TIB Molbiol Group, at an undisclosed price.

TIB Molbiol, which is headquartered in Berlin, specializes in providing reagents for research and medical diagnostics. Roche is expected to take over the ownership in the fourth quarter of 2021.

By acquiring TIB Molbiol, Roche will expand its field of work to detailed research and testing of infectious diseases, such as COVID-19.

Related Links: Roche Holding
Author:
Breaking the News / JR